Hao Tang
12Patents
3h-index
21Co-inventors
52Inventor score
Filing activity: Mar 25, 2016 → Aug 25, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10259882B2 | Anti-OX40 antibodies | Physics | 11 | Active |
| US10626181B2 | Nucleic acids encoding anti-OX40 antibodies | Physics | 5 | Active |
| US11249083B1 | Covid-19 spike-ACE2 binding assay for drug and antibody screening | Physics | 5 | Active |
| US11255855B1 | COVID-19 spike-ACE2 binding assay for drug and antibody screening | Physics | 2 | Active |
| US11105804B1 | COVID-19 spike-ACE2 binding assay for drug and antibody screening | Physics | 1 | Active |
| US11137395B1 | SARS-CoV-2 (COVID-19) spike-AXL binding assay | Physics | 0 | Active |
| US11136404B2 | Anti-OX40 antibodies | Physics | 0 | Active |
| US11053317B2 | Pharmaceutical preparation stably comprising CD147 monoclonal antibody | Chemistry; Metallurgy | 0 | Active |
| US11472883B2 | Methods of administering anti-OX40 antibodies | Physics | 0 | Active |
| US10855608B1 | Reconnect restriction evaluator | Electricity | 0 | Active |
| US11027016B2 | Pharmaceutical preparation stably comprising CD147 monoclonal antibody | Chemistry; Metallurgy | 0 | Active |
| US11332536B2 | Vectors comprising nucleic acids encoding anti-OX40 antibodies | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.